Dec 22, 20202 min readA busy, buzzy Vertex finds a high-profile partner in the RNA-drugging world to launch a fresh ...
Dec 22, 20202 min readVertex joins Skyhawk’s roster of A-list partners, securing options on RNA splicing modulators
Sep 29, 20202 min readThe Endpoints 11 : Here are some of the most promising startups in biotech. And Covid-19 isn’t ...
May 11, 20202 min readSkyhawk Therapeutics boosts Merck collab pact with added targets, upfront and biobucks
May 11, 20202 min readSkyhawk Therapeutics Announces Expansion of its Collaboration Agreement with Merck
May 11, 20202 min readMerck doubles down on Skyhawk’s tech to drug RNA, promising $600M per autoimmune, metabolic target
Feb 24, 20202 min readExperienced Business Leader in Biopharmaceutical Industry Joins as Chief Operating Officer
Nov 12, 20192 min readCelgene execs shell out $92M cash for a pair of R&D deals that will fit perfectly in their new home
Nov 9, 20192 min readSkyhawk Therapeutics Announces a Second Multi-Target Collaboration Agreement with Celgene
Jul 7, 20192 min readFattening the bankroll, Bill Haney adds cancer R&D powerhouse Merck to Skyhawk’s roster
Jul 7, 20191 min readBill Haney’s Skyhawk spears another marquee alliance for its work drugging RNA in Takeda neuro pact
Jan 4, 20192 min readJoining forces with Skyhawk, C4 Therapeutics, Biogen buys more shots on goal on SMA, Alzheimer’s
Jun 25, 20182 min readSkyhawk Announces Strategic Collaboration with Celgene to Discover and Develop Novel mRNA Splicing
Jun 25, 20181 min readBiotech Celgene inks $60M deal with newcomer Skyhawk to develop RNA drugs for ALS, Huntington’s
